The irbesartan recall is the latest involving a large class of blood pressure drugs called angiotensin II receptor blockers, which work by blocking the effects of a hormone that narrows blood vessels.

The FDA has already announced several recalls for irbesartan in the past few months. They've also issued recalls for a number of other blood pressure medications, including losartan and valsartan.

(CNN) -- The US Food and Drug Administration is alerting patients of another recall of medicine used to treat high blood pressure, for a potential cancer risk due to contamination. This time ...

This impurity has prompted the company to voluntarily recall specific lots of irbesartan tablets (USP 75 mg, 150 mg, and 300 mg dosage forms), according to the U.S. Food and Drug Administration (FDA).

Irbesartan tablets 300MG 90CT, NDC code 43547-376-09, Lot number 331B18009, Expiration date 02/2021. Irbesartan/HCTZ 300MG/12.5MG 30CT tablets, NDC code 43547-331-03, lot number 327A18001 ...

In fact, irbesartan specifically manufactured by Sciegen Pharmaceuticals, Inc. was already involved in a 2018 recall. Irbesartan may sound like the group that sang “Black Hole Sun.” ...

Lupin Pharmaceuticals is voluntarily recalling certain dosages of irbesartan tablets and irbesartan and hydrochlorothiazide tablets distributed in 30- and 90-count bottles nationwide.

The recall is due to unacceptable amounts of N-Nitrosodiethylamine (NDEA) in the irbesartan active pharmaceutical ingredient manufactured by Zhejiang Huahai Pharmaceuticals (ZHP).

Those voluntary recalls came after the discovery of the chemicals NDMA and NDEA -- both probable human carcinogens -- at levels far above what the FDA considers an acceptable daily intake.

Some Irbesartan tablets manufactured by ScieGen Pharmaceuticals and labeled as Westminster Pharmaceuticals and Golden State Medical Supply, Inc (GSMS) are impacted by the voluntary recall.

This recall affects about 1% of the irbesartan drug products in the US market, according to the FDA. Talk with your doctor or pharmacist before changing any medicine.